Clinical Trials Directory

Trials / Sponsors / Reistone Biopharma Company Limited

Reistone Biopharma Company Limited

Industry · 14 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary
Chronic Obstructive Pulmonary Disease
Phase 22026-03-10
RecruitingA Clinical Study of RSS0343 in Healthy Subjects
Non-cystic Fibrosis Bronchiectasis
Phase 12026-01-04
Active Not RecruitingA Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
Atopic Dermatitis of Adults
Phase 22025-09-25
UnknownEvaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata
Alopecia Areata
Phase 32022-04-18
UnknownEvaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy
Primary Membranous Nephropathy
Phase 22021-12-15
UnknownA Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerativ
Ulcerative Colitis
Phase 32021-11-05
CompletedEvaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopi
Atopic Dermatitis
Phase 32021-04-30
CompletedAn Open Label Study of the Effects of SHR1459 in NMOSDs Patients
Neuromyelitis Optica Spectrum Disorders
Phase 22021-01-20
UnknownEvaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatit
Atopic Dermatitis
Phase 2 / Phase 32020-12-30
CompletedA Phase II Study in Patients With Alopecia Areata
Alopecia Areata
Phase 22020-05-13
TerminatedAssess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo
Vitiligo
Phase 2 / Phase 32020-01-29
CompletedA Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 22019-11-06
CompletedA Phase II Study in Patients With Moderate to Severe Active Crohn's Disease
Crohn's Disease
Phase 22019-05-14
CompletedA Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.
Ulcerative Colitis
Phase 22019-04-13